|
|
 |
|
Viewing report
|
|
|
|
Vietnam Pharmaceuticals & Healthcare Report Q1 2008
Business Monitor International, Feb 2008, Pages: 64
Executive Summary 5
Vietnam Pharmaceutical And Healthcare Industry SWOT 6
Vietnam Political SWOT 7
Vietnam Economics SWOT 7
Vietnam Business Environment SWOT 8
Vietnam: Business Environment Rankings9
Pharmaceutical Ratings - Revised Methodology 9
Ratings Overview 9
Table: Pharmaceutical Business Environment Indicators 10
Weighting 11
Table: Weighting Of Components 11
Vietnam - Business Environment Rankings 12
Table: Pharmaceutical Business Environment Ratings 12
Limits Of Potential Returns 12
Risks To Realisation Of Returns 13
Market Summary 14
Regulatory Regime16
Pharmaceutical Advertising 16
Intellectual Property Environment 17
IP Shortcomings 17
Counterfeit Drugs 18
Other Regulatory Issues 19
Pricing And Reimbursement Regime 20
Recent Pricing Developments 21
Industry Trends And Developments 23
Healthcare Sector 23
Recent Public Health Developments 23
Healthcare Insurance 25
Healthcare And Pharmaceutical Reforms 25
Epidemiology 26
Foreign Partnerships 27
Domestic Pharmaceutical Sector 28
Retail Sector 29
Foreign Pharmaceutical Sector 30
Traditional Medicines 30
Research And Development 31
Biotechnology Sector 32
Industry Forecast Scenario 33
Overall Market Forecast 33
Table: Drug Expenditure Forecasts, 2006-2012 33
Key Growth Factors - Industry 34
Table: Vietnam Health Expenditure Forecast Indicators, 2006-2012 34
Key Growth Factors - Macroeconomic 35
Table: Vietnam - Economic Activity 36
Prescription Market Forecast 37
Table: Vietnam Prescription Drugs Market Forecast Indicators (US$mn unless otherwise stated) 38
OTC Market Forecast 39
Table: OTC Market Data Forecasts (US$mn unless otherwise stated) 40
Generic And Patented Market Forecasts 41
Table: Vietnam’s Generics And Patented Market Forecast Indicators, 2006-2012 42
Export/Import Forecasts 43
Table: Vietnam Pharmaceutical Trade Indicators (US$mn) 44
Other Healthcare Data Forecasts 44
Table: Other Health Indicators 44
Key Risks To our Forecast Scenario 45
Competitive Landscape46
Company Profiles47
Leading Multinational Manufacturers 47
Pfizer 47
GlaxoSmithKline 49
Sanofi-Aventis 51
Novartis 53
Merck & Co 55
Indigenous Manufacturer Profiles 56
Vietnam Pharmaceutical Corporation (Vinapharm) 56
Vietnam OPV Pharmaceutical Co 58
Stada Vietnam 59
Vidipha Central Pharmaceutical Joint Stock Company 61
BMI Forecast Modelling62
How We Generate Our Industry Forecasts 62
Pharmaceutical Industry 63
Sources 63
Customers who bought this item also bought
Vietnam Pharmaceuticals and Healthcare Report Q2 2008
Vietnam Pharmaceuticals and Healthcare Report Q3 2007
The Pharmaceutical Market: Vietnam
Vietnam Pharmaceuticals and Healthcare Report Q1 2009
Vietnam Pharmaceuticals and Healthcare Report Q4 2008
Vietnam Pharmaceuticals and Healthcare Report Q3 2008
Executive Report on Strategies in Vietnam
OTC Healthcare in Vietnam to 2010
Spain Pharmaceuticals and Healthcare Report Q4 2009
Kazakhstan Pharmaceuticals and Healthcare Report Q3 2008
The Medical Device Market: Vietnam
Czech Republic Pharmaceuticals and Healthcare Report Q3 2009
|
|
|
|
